San Diego-primarily based Viking Therapeutics marked alone as a serious competitor within the weight loss drug marketplace in February right after revealing promising details from the mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when given as being a weekly injection and in March